Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.45 CHF | +0.55% | -5.52% | +6.20% |
Feb. 16 | BB Biotech's Loss Narrows in FY23; Operating Income Down | MT |
Feb. 14 | BB Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar BB Biotech AG
Upcoming events on BB Biotech AG
Past events on BB Biotech AG
2024-03-24 | Ex-dividend day for final dividend |
2024-03-21 10:00 am | Annual General Meeting |
2024-01-19 01:00 am | Q4 2023 Earnings Release |
2023-10-20 01:00 am | Q3 2023 Earnings Release |
2023-07-21 01:00 am | Q2 2023 Earnings Release |
2023-04-21 01:00 am | Q1 2023 Earnings Release |
2023-03-26 | Ex-dividend day for final dividend |
2023-03-23 10:00 am | Annual General Meeting |
2023-02-17 01:00 am | FY 2022 Earnings Release |
2022-10-21 01:00 am | Q3 2022 Earnings Release |
2022-07-22 01:00 am | Interim 2022 Earnings Release |
2022-04-22 01:00 am | Q1 2022 Earnings Release |
2022-03-20 | Ex-dividend day for final dividend |
2022-03-16 | Annual General Meeting |
2022-02-18 01:00 am | FY 2021 Earnings Release |
2021-10-22 01:00 am | Q3 2021 Earnings Release |
2021-07-23 01:00 am | Interim 2021 Earnings Release |
2021-04-23 01:00 am | Q1 2021 Earnings Release |
2021-03-21 | Ex-dividend day for final dividend |
2021-03-18 10:00 am | Annual General Meeting |
Past dividends on BB Biotech AG
2024-03-24 | Annual 2 CHF |
2023-03-26 | Annual 2.85 CHF |
2022-03-20 | Annual 3.85 CHF |
2021-03-21 | Annual 3.6 CHF |
2020-03-22 | Annual 3.4 CHF |
2019-03-24 | Annual 3.05 CHF |
2018-03-14 | Annual 3.3 CHF |
2017-03-19 | Annual 2.75 CHF |
2016-03-20 | 12.25 CHF |
2016-03-20 | Annual 2.25 CHF |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 728 209 247.91% | 742 0,54 137140.33% | 0,00 159 -100% | -314 -298 -5.35% | -167 -55,6 -199.66% | 32,1 |
EBITDA Million CHF | Released Forecast Spread | 680 337 101.76% | 694 208 233.01% | -403 434 -192.92% | -357 -49,3 -625.45% | -201 -21,2 -851.57% | 60,8 |
EBIT Million CHF | Released Forecast Spread | 679 471 44.09% | 692 330 109.72% | -404 317 -227.37% | -357 -49,3 -625.45% | -201 -21,2 -851.57% | 60,8 |
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 677 0,00 - | 691 126 448.02% | -405 101 -500.73% | -358 -360 0.49% | -207 -215 3.78% | -8,80 |
Net income Million CHF | Released Forecast Spread | 677 353 92.1% | 691 126 449.54% | -405 374 -208.38% | -358 -50,3 -612.44% | -207 -141 -46.22% | 25,5 |
EPS CHF | Released Forecast Spread | 12,2 0,00 - | 12,5 3,76 231.91% | -7,31 7,78 -193.96% | -6,50 -6,49 -0.15% | -3,77 -2,57 -46.69% | 0,50 |
Announcement Date | 21/02/20 | 19/02/21 | 18/02/22 | 17/02/23 | 16/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 |
---|---|---|---|
Net income Million CHF | Released Forecast Spread | -300 | -233 -219 -6.42% |
EPS CHF | Released Forecast Spread | -5,43 | |
Announcement Date | 22/04/22 | 22/07/22 |
Past sector events for BB Biotech AG
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock BB Biotech AG - Swiss Exchange
- Calendar BB Biotech AG